Blood test may spot liver cancer comeback early

NCT ID NCT05375370

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a blood test that looks for tiny bits of tumor DNA (ctDNA) can predict if liver cancer will come back after surgery. Researchers will take blood samples before and after surgery, then at 3 and 6 months, from 150 adults with liver cancer. The goal is to see if changes in ctDNA levels can warn of recurrence sooner than standard scans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test that catches liver cancer recurrence earlier than current methods.

What could go wrong

This is an early observational study with only 150 participants, so results may not apply to all patients. The test may not reliably predict recurrence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chu Rouen

    RECRUITING

    Rouen, 76031, France

    Contact

    Contact